Publisher: DelveInsight Published: Last 2 Years-
Liver Cirrhosis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Liver Cirrhosis market size in the 7MM was nearly USD 3,100 million in 2023, which is further anticipated to increase with a siginificant CAGR during the forecast period from (2024-2034). Liver cirrhosis is a chronic and progressive liver disease characterized by the replacement o ... Read More
-
Bullous Keratopathy - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 192 thousand diagnosed Bullous Keratopathy prevalent cases in the 7MM. Of these, the United States accounted for 41% of the cases, while Germany and Japan represented 13% and 9% of the cases, respectively. The bu ... Read More
-
Need some help finding the right information ?Verify before you buy
or call us
US toll free: 800.298.5699
Worldwide: +1.240.747.3093
-
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The total market size in the 7MM for multiple myeloma was estimated to be nearly USD 21,300 million in 2023, which is expected to show positive growth by 2034, owing to rise in incident cases, label expansion and penetration of current therapies in earlier lines, high adoption of newe ... Read More
-
IgG4-Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights IgG4-RD can affect virtually any organ, with common presentations including the pancreas, bile ducts, salivary glands, lacrimal glands, orbits, kidneys, lungs, and retroperitoneum. The true prevalence of IgG4-RD is unknown. Given its relatively recent discovery, lack of widespread rec ... Read More
-
Idiopathic Inflammatory Myositis - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 48% of the cases, while EU4 and the UK accounted for nearly 38% and Japan represented 14 ... Read More
-
Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Ulcerative Colitis Market Size in the 7MM was around USD 8,400 Million in 2023. The Ulcerative Colitis Market is anticipated to witness a positive shift owing to better uptake of existing drugs, and raised awareness. Ulcerative Colitis treatment is complex and comprises the use of ... Read More
-
Sickle Cell Disease (SCD) - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights Sickle cell disease (SCD) is a genetic blood disorder characterized by the presence of abnormal hemoglobin, causing red blood cells to become sickle-shaped. SCD is a global health concern, particularly prevalent in populations with African, Middle Eastern, Mediterranean, and South Asi ... Read More
-
Uveitic Glaucoma - Pipeline Insight, 2025
Uveitic Glaucoma Overview ""Uveitic Glaucoma Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Uveitic Glaucoma market. A detailed picture of the Uveitic Glaucoma pipeline landscape is provided, whi ... Read More
-
5-Alpha Reductase Inhibitor - Pipeline Insight, 2025
“5-Alpha Reductase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-Alpha Reductase Inhibitor development. The report provides detailed coverage of the pipeline landscape f ... Read More
-
5-HT1A Antagonist - Pipeline Insight, 2025
“5-HT1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
5-HT2A Agonists - Pipeline Insight, 2025
DelveInsight’s, “5-HT2A Agonists - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics a ... Read More
-
5-HT1D Agonist - Pipeline Insight, 2025
DelveInsight’s, “5-HT1D Agonist - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in 5-HT1D Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ass ... Read More
-
5-HT2B Antagonist - Pipeline Insight, 2025
“5-HT2B Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
5-HT6 Antagonist - Pipeline Insight, 2025
“5-HT6 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT6 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-HT2C Antagonist - Pipeline Insight, 2025
“5-HT2C Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025
“Adenosine A2A Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Agonist development. The report provides detailed coverage of the pipeline lands ... Read More
-
Adrenergic Antagonist - Pipeline Insight, 2025
“Adrenergic Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adrenergic Antagonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025
“Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist development. The rep ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025
“Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- development. The report provides detailed coverage ... Read More
-
Androgen Agonist - Pipeline Insight, 2025
“Androgen Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator development. The repor ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor development. The repor ... Read More
-
Anti-CD37 Antibody - Pipeline Insight, 2025
“Anti-CD37 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2025
“Anti-CD3 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
Anti-CD40 Antibody - Pipeline Insight, 2025
DelveInsight’s, “Anti-CD40 Antibody - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Anti-CD40 Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
Research Assistance